Skip to main content
Premium Trial:

Request an Annual Quote

Quotient Bioresearch to Buy Three Thermo Fisher Orbitraps

NEW YORK (GenomeWeb news) – Quotient Bioresearch said today that it will buy three mass spectrometers from Thermo Fisher Scientific.
 
Cambridge, UK-based Quotient Bioresearch will use the three new LTQ Orbitrap XL mass spectrometers for use in its drug development and sports testing services.
 
The company said the new tools are part of its program to continue to develop its metabolite identification services, in part because the US Food and Drug Administration is “driving the need to identify and quantitate key metabolites at the early stage of the drug development process.”
 
The TFS mass spectrometers support small-molecule metabolite profiling and will enable Quotient Bioresearch to extract metabolite information from early toxicology and clinical research samples.
 
Financial terms of the agreement were not released.
 

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.